CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 101 filers reported holding CUE BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 16 | -99.9% | 0.00% | – |
| Q1 2022 | $108,000 | -53.4% | 22,053 | +7.2% | 0.00% | – |
| Q4 2021 | $232,000 | -0.4% | 20,580 | +28.8% | 0.00% | – |
| Q3 2021 | $233,000 | -7.5% | 15,981 | -26.1% | 0.00% | – |
| Q2 2021 | $252,000 | -10.0% | 21,628 | -5.7% | 0.00% | – |
| Q1 2021 | $280,000 | -59.7% | 22,943 | -58.6% | 0.00% | – |
| Q4 2020 | $694,000 | -21.3% | 55,459 | -5.4% | 0.00% | -100.0% |
| Q3 2020 | $882,000 | -32.4% | 58,617 | +10.1% | 0.00% | 0.0% |
| Q2 2020 | $1,305,000 | – | 53,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Corriente Advisors, LLC | 1,437,445 | $21,634,000 | 10.97% |
| Prosight Management, LP | 709,936 | $10,685,000 | 5.08% |
| Voss Capital, LLC | 226,573 | $3,410,000 | 1.94% |
| Robertson Stephens Wealth Management, LLC | 484,000 | $7,284,000 | 1.79% |
| Slate Path Capital LP | 1,483,619 | $22,328,000 | 1.27% |
| Nantahala Capital Management | 2,342,216 | $35,250,000 | 1.08% |
| SANDERS MORRIS HARRIS LLC | 142,430 | $2,312,000 | 0.63% |
| Rock Creek Group, LP | 80,000 | $1,204,000 | 0.62% |
| PRECEPT MANAGEMENT LLC | 150,000 | $2,258,000 | 0.55% |
| PA Capital LLC | 46,850 | $705,000 | 0.50% |